Global Clinical Trials Support Service Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Clinical Trials Support Service Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Report Code: KNJ1028421 | No. of Pages: 102 | Category: Telecom and IT
Publisher: GRD Survey | Date of Publish: Nov-2021
Executive Summary

According to GRD Survey data, the global Clinical Trials Support Service market was valued at  million US$ in 2020 and is expected to  million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Clinical Trials Support Service market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Clinical Trials Support Service in these regions, from 2016 to 2027, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
    Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
    South America (Brazil, Argentina, Colombia, etc.)
    Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
    Clinical Trial Site Management

    Patient Recruitment Management

    Data Management

    Administrative Staff

    IRB

    Others

Market Snapshot, By Application
    Pharmaceutical and Biopharmaceutical Companies

    Medical Device Companies

    Others

Main Market Players Analyzed in this report, including:
    WuXi AppTec

    The Leukemia & Lymphoma Society (LLS)

    Pharmaceutical Product Development LLC

    Parexel International

    Novotech

    Laboratory Corp. of America Holdings

    Kaiser Permanente

    IQVIA

    Icon PLC

    eukemia & Lymphoma Society (LLS)

    Clinical Trial Service BV (CTS

    Charles River Laboratories


The study objectives of this report are:
    To study and analyze the global Clinical Trials Support Service market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
    To understand industry structure of Clinical Trials Support Service market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To identify the key global Clinical Trials Support Service manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Clinical Trials Support Service market with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Clinical Trials Support Service submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Clinical Trials Support Service are as follows:
    History Year: 2016-2020
    Base Year: 2020
    Estimated Year: 2021
    Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1  Market Definition & Scope
    1.1  Definition & Scope
    1.2 Clinical Trials Support Service Product Specifications
    1.3  Main Events (Entry, M&A, Exit, Technology and Capital Activity)
    1.4 Global Clinical Trials Support Service Market Performance and Outlook

2 Market Development Performance under COVID-19
    2.1 Influencing Factors of Industry Development in the Next Five Years
        2.1.1 Drivers
        2.1.2 Restraints
        2.1.3 Opportunities
    2.2 Porter’s Five Forces Analysis
    2.3 Comparison of Alternatives and Clinical Trials Support Service

3 3 Industrial Lift Cycle and Main Buyers Analysis
    3.1 Industry Life Cycle Analysis
    3.2 Key Buying Industries/Consumers
        3.2.1 Major Buyers in Pharmaceutical and Biopharmaceutical Companies

        3.2.2 Major Buyers in Medical Device Companies


4 Market Segment: by Type
    4.1 Clinical Trials Support Service Type Introduction
        4.1.1 Clinical Trial Site Management

        4.1.2 Patient Recruitment Management

        4.1.3 Data Management

        4.1.4 Administrative Staff

        4.1.5 IRB

        4.1.6 Others
    4.2 Global Clinical Trials Support Service Revenue by Type 2016-2021

5 Market Segment: by Application
    5.1 Clinical Trials Support Service Type Introduction
        5.1.1 Pharmaceutical and Biopharmaceutical Companies

        5.1.2 Medical Device Companies

        5.1.3 Others
    5.2 Global Clinical Trials Support Service Revenue by Application 2016-2021

6 Marke Segment: by Region
    6.1 Global Clinical Trials Support Service Market by Region
    6.2 North America Clinical Trials Support Service Market 2016-2021
    6.3 Europe Clinical Trials Support Service Market 2016-2021
    6.4 Asia Pacific Clinical Trials Support Service Market 2016-2021
    6.5 South America Clinical Trials Support Service Market 2016-2021
    6.6 Middle East and Africa Clinical Trials Support Service Market 2016-2021

7 North America
    7.1 North America Clinical Trials Support Service Market by Country 2016-2021
    7.2 United States
    7.3 Canada
    7.4 Mexico

8 Europe
    8.1 Europe Clinical Trials Support Service Market by Country 2016-2021
    8.2 Germany
    8.3 France
    8.4 UK
    8.5 Italy
    8.6 Russia
    8.7 Spain

9 Asia Pacific
    9.1 Asia Pacific Clinical Trials Support Service Market by Country 2016-2021
    9.2 China
    9.3 Japan
    9.4 Korea
    9.5 Southeast Asia
    9.6 India
    9.7 Australia

10 South America
    10.1 South America Clinical Trials Support Service Market by Country 2016-2021
    10.2 Brazil
    10.3 Argentina
    10.4 Colombia

11 Middle East and Africa
    11.1 Middle East and Africa Clinical Trials Support Service Market by Country 2016-2021
    11.2 Turkey
    11.3 Saudi Arabia
    11.4 South Africa

12 Key Participants Company Information
    12.1 WuXi AppTec

        12.1.1 WuXi AppTec
 Company Information
        12.1.2 WuXi AppTec
 Clinical Trials Support Service Product Portfolio, Specification and Application
        12.1.3 WuXi AppTec
 Clinical Trials Support Service Revenue and Gross Margin (2019-2021)
        12.1.4 WuXi AppTec
 Key Development
    12.2 The Leukemia & Lymphoma Society (LLS)

        12.2.1 The Leukemia & Lymphoma Society (LLS)
 Company Information
        12.2.2 The Leukemia & Lymphoma Society (LLS)
 Clinical Trials Support Service Product Portfolio, Specification and Application
        12.2.3 The Leukemia & Lymphoma Society (LLS)
 Clinical Trials Support Service Revenue and Gross Margin (2019-2021)
        12.2.4 The Leukemia & Lymphoma Society (LLS)
 Key Development
    12.3 Pharmaceutical Product Development LLC

        12.3.1 Pharmaceutical Product Development LLC
 Company Information
        12.3.2 Pharmaceutical Product Development LLC
 Clinical Trials Support Service Product Portfolio, Specification and Application
        12.3.3 Pharmaceutical Product Development LLC
 Clinical Trials Support Service Revenue and Gross Margin (2019-2021)
        12.3.4 Pharmaceutical Product Development LLC
 Key Development
    12.4 Parexel International

        12.4.1 Parexel International
 Company Information
        12.4.2 Parexel International
 Clinical Trials Support Service Product Portfolio, Specification and Application
        12.4.3 Parexel International
 Clinical Trials Support Service Revenue and Gross Margin (2019-2021)
        12.4.4 Parexel International
 Key Development
    12.5 Novotech

        12.5.1 Novotech
 Company Information
        12.5.2 Novotech
 Clinical Trials Support Service Product Portfolio, Specification and Application
        12.5.3 Novotech
 Clinical Trials Support Service Revenue and Gross Margin (2019-2021)
        12.5.4 Novotech
 Key Development
    12.6 Laboratory Corp. of America Holdings

        12.6.1 Laboratory Corp. of America Holdings
 Company Information
        12.6.2 Laboratory Corp. of America Holdings
 Clinical Trials Support Service Product Portfolio, Specification and Application
        12.6.3 Laboratory Corp. of America Holdings
 Clinical Trials Support Service Revenue and Gross Margin (2019-2021)
        12.6.4 Laboratory Corp. of America Holdings
 Key Development
    12.7 Kaiser Permanente

        12.7.1 Kaiser Permanente
 Company Information
        12.7.2 Kaiser Permanente
 Clinical Trials Support Service Product Portfolio, Specification and Application
        12.7.3 Kaiser Permanente
 Clinical Trials Support Service Revenue and Gross Margin (2019-2021)
        12.7.4 Laboratory Corp. of America Holdings
 Key Development
    12.9 Icon PLC

        12.9.1 Icon PLC
 Company Information
        12.9.2 Icon PLC
 Clinical Trials Support Service Product Portfolio, Specification and Application
        12.9.3 Icon PLC
 Clinical Trials Support Service Revenue and Gross Margin (2019-2021)
        12.9.4 Icon PLC
 Key Development
    12.8 IQVIA

        12.8.1 IQVIA
 Company Information
        12.8.2 IQVIA
 Clinical Trials Support Service Product Portfolio, Specification and Application
        12.8.3 IQVIA
 Clinical Trials Support Service Revenue and Gross Margin (2019-2021)
        12.8.4 IQVIA
 Key Development
    12.11 Clinical Trial Service BV (CTS

        12.11.1 Clinical Trial Service BV (CTS
 Company Information
        12.11.2 Clinical Trial Service BV (CTS
 Clinical Trials Support Service Product Portfolio, Specification and Application
        12.11.3 Clinical Trial Service BV (CTS
 Clinical Trials Support Service Revenue and Gross Margin (2019-2021)
        12.11.4 Clinical Trial Service BV (CTS
 Key Development
    12.12 Charles River Laboratories

        12.12.1 Charles River Laboratories
 Company Information
        12.12.2 Charles River Laboratories
 Clinical Trials Support Service Product Portfolio, Specification and Application
        12.12.3 Charles River Laboratories
 Clinical Trials Support Service Revenue and Gross Margin (2019-2021)
        12.12.4 Charles River Laboratories
 Key Development

13 Global Clinical Trials Support Service Market Forecast by Region by Type and by Application
    13.1 Global Clinical Trials Support Service Revenue Forecast 2022-2027
    13.2 Global Clinical Trials Support Service Forecast by Regions
    13.3 Global Clinical Trials Support Service Forecast by Type
    13.4 Global Clinical Trials Support Service Forecast by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source
    15.1 Methodology
    15.2 Research Data Source
        15.2.1 Secondary Data
        15.2.2 Primary Data
        15.2.3 Market Size Estimation
    15.3 Legal Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com